nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.00987	0.0937	CbGpPWpGaD
Treprostinil—PTGIR—Prostacyclin signalling through prostacyclin receptor—GNAS—peripheral nervous system neoplasm	0.00654	0.062	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00442	0.042	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—NF2—peripheral nervous system neoplasm	0.0044	0.0417	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	0.0042	0.0399	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00418	0.0397	CbGpPWpGaD
Treprostinil—PPARD—The citric acid (TCA) cycle and respiratory electron transport—COX2—peripheral nervous system neoplasm	0.00328	0.0311	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00281	0.0267	CbGpPWpGaD
Treprostinil—Nadolol—ABCB1—peripheral nervous system neoplasm	0.00231	1	CrCbGaD
Treprostinil—PTGIR—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.00211	0.02	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00192	0.0182	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00177	0.0168	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.00175	0.0166	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00167	0.0158	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.00147	0.0139	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00146	0.0139	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00146	0.0138	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0014	0.0133	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—MYC—peripheral nervous system neoplasm	0.00138	0.0131	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00135	0.0128	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.00134	0.0127	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00129	0.0123	CbGpPWpGaD
Treprostinil—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00128	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.00114	0.0108	CbGpPWpGaD
Treprostinil—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00128	CcSEcCtD
Treprostinil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00128	CcSEcCtD
Treprostinil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00128	CcSEcCtD
Treprostinil—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00113	0.00127	CcSEcCtD
Treprostinil—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00127	CcSEcCtD
Treprostinil—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00126	CcSEcCtD
Treprostinil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00112	0.00126	CcSEcCtD
Treprostinil—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00126	CcSEcCtD
Treprostinil—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00126	CcSEcCtD
Treprostinil—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00112	0.00126	CcSEcCtD
Treprostinil—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00112	0.00125	CcSEcCtD
Treprostinil—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00125	CcSEcCtD
Treprostinil—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00111	0.00125	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00111	0.00125	CcSEcCtD
Treprostinil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00124	CcSEcCtD
Treprostinil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00111	0.00124	CcSEcCtD
Treprostinil—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00124	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00111	0.00124	CcSEcCtD
Treprostinil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0011	0.00123	CcSEcCtD
Treprostinil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.00123	CcSEcCtD
Treprostinil—Insomnia—Vincristine—peripheral nervous system neoplasm	0.0011	0.00123	CcSEcCtD
Treprostinil—PPARD—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0011	0.0104	CbGpPWpGaD
Treprostinil—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00123	CcSEcCtD
Treprostinil—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00109	0.00122	CcSEcCtD
Treprostinil—Malaise—Etoposide—peripheral nervous system neoplasm	0.00109	0.00122	CcSEcCtD
Treprostinil—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00122	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00109	0.0103	CbGpPWpGaD
Treprostinil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00121	CcSEcCtD
Treprostinil—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.0012	CcSEcCtD
Treprostinil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.0012	CcSEcCtD
Treprostinil—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00107	0.0012	CcSEcCtD
Treprostinil—Infection—Cisplatin—peripheral nervous system neoplasm	0.00107	0.0012	CcSEcCtD
Treprostinil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00107	0.00119	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00119	CcSEcCtD
Treprostinil—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00106	0.00119	CcSEcCtD
Treprostinil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00119	CcSEcCtD
Treprostinil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00119	CcSEcCtD
Treprostinil—Rash—Topotecan—peripheral nervous system neoplasm	0.00106	0.00118	CcSEcCtD
Treprostinil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00106	0.00118	CcSEcCtD
Treprostinil—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00106	0.00118	CcSEcCtD
Treprostinil—Cough—Etoposide—peripheral nervous system neoplasm	0.00105	0.00118	CcSEcCtD
Treprostinil—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00118	CcSEcCtD
Treprostinil—Headache—Topotecan—peripheral nervous system neoplasm	0.00105	0.00118	CcSEcCtD
Treprostinil—Rash—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00118	CcSEcCtD
Treprostinil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00118	CcSEcCtD
Treprostinil—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00117	CcSEcCtD
Treprostinil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00117	CcSEcCtD
Treprostinil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00117	CcSEcCtD
Treprostinil—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00105	0.00117	CcSEcCtD
Treprostinil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00104	0.00117	CcSEcCtD
Treprostinil—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00117	CcSEcCtD
Treprostinil—Headache—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00117	CcSEcCtD
Treprostinil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00117	CcSEcCtD
Treprostinil—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00116	CcSEcCtD
Treprostinil—Pain—Vincristine—peripheral nervous system neoplasm	0.00104	0.00116	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00116	CcSEcCtD
Treprostinil—Rash—Melphalan—peripheral nervous system neoplasm	0.00104	0.00116	CcSEcCtD
Treprostinil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00103	0.00116	CcSEcCtD
Treprostinil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00116	CcSEcCtD
Treprostinil—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00103	0.00115	CcSEcCtD
Treprostinil—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00115	CcSEcCtD
Treprostinil—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00114	CcSEcCtD
Treprostinil—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00101	0.00114	CcSEcCtD
Treprostinil—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.001	0.00112	CcSEcCtD
Treprostinil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.00112	CcSEcCtD
Treprostinil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.00112	CcSEcCtD
Treprostinil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000996	0.00112	CcSEcCtD
Treprostinil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000993	0.00111	CcSEcCtD
Treprostinil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000988	0.00111	CcSEcCtD
Treprostinil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000988	0.00111	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000978	0.0011	CcSEcCtD
Treprostinil—Infection—Etoposide—peripheral nervous system neoplasm	0.000977	0.0011	CcSEcCtD
Treprostinil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000975	0.00109	CcSEcCtD
Treprostinil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000975	0.00109	CcSEcCtD
Treprostinil—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00097	0.00109	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000966	0.00108	CcSEcCtD
Treprostinil—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000964	0.00108	CcSEcCtD
Treprostinil—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000963	0.00108	CcSEcCtD
Treprostinil—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00096	0.00108	CcSEcCtD
Treprostinil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00096	0.00108	CcSEcCtD
Treprostinil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00096	0.00108	CcSEcCtD
Treprostinil—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000957	0.00107	CcSEcCtD
Treprostinil—PPARD—Gene Expression—EED—peripheral nervous system neoplasm	0.000954	0.00905	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.00095	0.00902	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00095	0.00901	CbGpPWpGaD
Treprostinil—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000945	0.00106	CcSEcCtD
Treprostinil—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000938	0.00105	CcSEcCtD
Treprostinil—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000934	0.00105	CcSEcCtD
Treprostinil—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000933	0.00886	CbGpPWpGaD
Treprostinil—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000933	0.00105	CcSEcCtD
Treprostinil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00093	0.00104	CcSEcCtD
Treprostinil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000919	0.00103	CcSEcCtD
Treprostinil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000918	0.00103	CcSEcCtD
Treprostinil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000904	0.00101	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000897	0.00101	CcSEcCtD
Treprostinil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000892	0.000999	CcSEcCtD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000889	0.00844	CbGpPWpGaD
Treprostinil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000885	0.000992	CcSEcCtD
Treprostinil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000883	0.00099	CcSEcCtD
Treprostinil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000877	0.000983	CcSEcCtD
Treprostinil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000871	0.000977	CcSEcCtD
Treprostinil—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00087	0.000975	CcSEcCtD
Treprostinil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000864	0.000969	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000864	0.0082	CbGpPWpGaD
Treprostinil—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000863	0.000967	CcSEcCtD
Treprostinil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000862	0.000966	CcSEcCtD
Treprostinil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000857	0.000961	CcSEcCtD
Treprostinil—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000855	0.000958	CcSEcCtD
Treprostinil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000849	0.000951	CcSEcCtD
Treprostinil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000848	0.000951	CcSEcCtD
Treprostinil—Pain—Etoposide—peripheral nervous system neoplasm	0.000841	0.000943	CcSEcCtD
Treprostinil—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000841	0.000942	CcSEcCtD
Treprostinil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000833	0.000934	CcSEcCtD
Treprostinil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000831	0.000931	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000827	0.00785	CbGpPWpGaD
Treprostinil—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000824	0.000924	CcSEcCtD
Treprostinil—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000816	0.000914	CcSEcCtD
Treprostinil—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000811	0.000909	CcSEcCtD
Treprostinil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000811	0.000909	CcSEcCtD
Treprostinil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000807	0.000905	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000805	0.000902	CcSEcCtD
Treprostinil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000805	0.000902	CcSEcCtD
Treprostinil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000803	0.0009	CcSEcCtD
Treprostinil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000801	0.000898	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000795	0.00754	CbGpPWpGaD
Treprostinil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000795	0.000891	CcSEcCtD
Treprostinil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000794	0.00089	CcSEcCtD
Treprostinil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00079	0.000886	CcSEcCtD
Treprostinil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00079	0.000885	CcSEcCtD
Treprostinil—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00078	0.000874	CcSEcCtD
Treprostinil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000778	0.000872	CcSEcCtD
Treprostinil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000778	0.000872	CcSEcCtD
Treprostinil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000778	0.000872	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000778	0.000872	CcSEcCtD
Treprostinil—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000776	0.00087	CcSEcCtD
Treprostinil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000772	0.000865	CcSEcCtD
Treprostinil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000771	0.000864	CcSEcCtD
Treprostinil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00077	0.000863	CcSEcCtD
Treprostinil—Rash—Vincristine—peripheral nervous system neoplasm	0.000766	0.000858	CcSEcCtD
Treprostinil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000765	0.000857	CcSEcCtD
Treprostinil—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000857	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000763	0.000855	CcSEcCtD
Treprostinil—PPARD—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000763	0.00724	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000761	0.00722	CbGpPWpGaD
Treprostinil—Headache—Vincristine—peripheral nervous system neoplasm	0.000761	0.000853	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.000846	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000751	0.00713	CbGpPWpGaD
Treprostinil—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000751	0.000841	CcSEcCtD
Treprostinil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000749	0.000839	CcSEcCtD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—AKT1—peripheral nervous system neoplasm	0.000743	0.00705	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000742	0.00704	CbGpPWpGaD
Treprostinil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000735	0.000823	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.000819	CcSEcCtD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—peripheral nervous system neoplasm	0.000728	0.00691	CbGpPWpGaD
Treprostinil—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.000809	CcSEcCtD
Treprostinil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000721	0.000809	CcSEcCtD
Treprostinil—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00072	0.000807	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00072	0.00683	CbGpPWpGaD
Treprostinil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00072	0.000807	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000718	0.000805	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000713	0.000799	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000793	CcSEcCtD
Treprostinil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000706	0.000791	CcSEcCtD
Treprostinil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000696	0.00078	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000691	0.00656	CbGpPWpGaD
Treprostinil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000683	0.000765	CcSEcCtD
Treprostinil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000677	0.000759	CcSEcCtD
Treprostinil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000677	0.000758	CcSEcCtD
Treprostinil—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000676	0.000757	CcSEcCtD
Treprostinil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000673	0.000754	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000747	CcSEcCtD
Treprostinil—Tension—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000743	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000663	0.00629	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000658	0.00624	CbGpPWpGaD
Treprostinil—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000656	0.000736	CcSEcCtD
Treprostinil—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000654	0.000733	CcSEcCtD
Treprostinil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000651	0.000729	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00065	0.000728	CcSEcCtD
Treprostinil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000638	0.000715	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000635	0.00602	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000627	0.000703	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000627	0.00595	CbGpPWpGaD
Treprostinil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000626	0.000701	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000701	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000625	0.0007	CcSEcCtD
Treprostinil—Rash—Etoposide—peripheral nervous system neoplasm	0.00062	0.000695	CcSEcCtD
Treprostinil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00062	0.000695	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000616	0.00585	CbGpPWpGaD
Treprostinil—Headache—Etoposide—peripheral nervous system neoplasm	0.000616	0.000691	CcSEcCtD
Treprostinil—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.000688	CcSEcCtD
Treprostinil—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000683	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000607	0.000681	CcSEcCtD
Treprostinil—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000679	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000605	0.00574	CbGpPWpGaD
Treprostinil—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000605	0.000678	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.000674	CcSEcCtD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—peripheral nervous system neoplasm	0.000598	0.00568	CbGpPWpGaD
Treprostinil—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000597	0.000669	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000594	0.000666	CcSEcCtD
Treprostinil—Cough—Epirubicin—peripheral nervous system neoplasm	0.00059	0.000661	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000588	0.00558	CbGpPWpGaD
Treprostinil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000584	0.000655	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000584	0.00554	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.00065	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000648	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000577	0.00547	CbGpPWpGaD
Treprostinil—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000645	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000645	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000645	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000575	0.00546	CbGpPWpGaD
Treprostinil—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000643	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000572	0.00543	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000569	0.0054	CbGpPWpGaD
Treprostinil—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000637	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000632	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000628	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000553	0.000619	CcSEcCtD
Treprostinil—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000552	0.000618	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000616	CcSEcCtD
Treprostinil—Infection—Epirubicin—peripheral nervous system neoplasm	0.000548	0.000614	CcSEcCtD
Treprostinil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000611	CcSEcCtD
Treprostinil—Shock—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000608	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000541	0.00514	CbGpPWpGaD
Treprostinil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00054	0.000605	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000603	CcSEcCtD
Treprostinil—PPARD—Metabolism—GNS—peripheral nervous system neoplasm	0.000536	0.00509	CbGpPWpGaD
Treprostinil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000597	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000597	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000597	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.000595	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000529	0.00502	CbGpPWpGaD
Treprostinil—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000589	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000526	0.000589	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000525	0.00499	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000524	0.00497	CbGpPWpGaD
Treprostinil—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000578	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000514	0.00488	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NME1—peripheral nervous system neoplasm	0.000514	0.00488	CbGpPWpGaD
Treprostinil—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.000572	CcSEcCtD
Treprostinil—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.000568	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000563	CcSEcCtD
Treprostinil—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000563	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.00056	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000559	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000558	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000555	CcSEcCtD
Treprostinil—PPARD—Metabolism—COX2—peripheral nervous system neoplasm	0.000495	0.0047	CbGpPWpGaD
Treprostinil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000551	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—HGF—peripheral nervous system neoplasm	0.00049	0.00465	CbGpPWpGaD
Treprostinil—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000545	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000544	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000484	0.00459	CbGpPWpGaD
Treprostinil—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000537	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000534	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000533	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000473	0.00449	CbGpPWpGaD
Treprostinil—Pain—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000529	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000521	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000517	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000514	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.00051	CcSEcCtD
Treprostinil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000509	CcSEcCtD
Treprostinil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000505	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—HGF—peripheral nervous system neoplasm	0.000451	0.00428	CbGpPWpGaD
Treprostinil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000503	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000444	0.00421	CbGpPWpGaD
Treprostinil—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.000497	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000493	CcSEcCtD
Treprostinil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000489	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000489	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000489	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000425	0.00404	CbGpPWpGaD
Treprostinil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000471	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000468	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000408	0.00388	CbGpPWpGaD
Treprostinil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000452	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000452	CcSEcCtD
Treprostinil—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000443	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000392	0.00372	CbGpPWpGaD
Treprostinil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000437	CcSEcCtD
Treprostinil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000423	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000372	0.00353	CbGpPWpGaD
Treprostinil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.00041	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000409	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000405	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000357	0.00339	CbGpPWpGaD
Treprostinil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000393	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000391	CcSEcCtD
Treprostinil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000348	0.00039	CcSEcCtD
Treprostinil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000389	CcSEcCtD
Treprostinil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000387	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000342	0.00325	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000338	0.0032	CbGpPWpGaD
Treprostinil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000378	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000336	0.00319	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000335	0.00318	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000329	0.00312	CbGpPWpGaD
Treprostinil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000367	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000325	0.00308	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ENO2—peripheral nervous system neoplasm	0.000325	0.00308	CbGpPWpGaD
Treprostinil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000364	CcSEcCtD
Treprostinil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000361	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.00036	CcSEcCtD
Treprostinil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000358	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000311	0.00295	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00031	0.00294	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00031	0.00294	CbGpPWpGaD
Treprostinil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.00034	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000299	0.00284	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000295	0.0028	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000286	0.00271	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—BCHE—peripheral nervous system neoplasm	0.000275	0.0026	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000272	0.00258	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000269	0.00256	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000262	0.00248	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TH—peripheral nervous system neoplasm	0.000258	0.00245	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000233	0.00221	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000221	0.0021	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000219	0.00208	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000215	0.00204	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000215	0.00204	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GNAS—peripheral nervous system neoplasm	0.000211	0.002	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000207	0.00196	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000205	0.00195	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000199	0.00189	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000198	0.00188	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00019	0.0018	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000189	0.00179	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000184	0.00174	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000175	0.00166	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000174	0.00165	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—peripheral nervous system neoplasm	0.000164	0.00156	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00016	0.00152	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000157	0.00149	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—peripheral nervous system neoplasm	0.000151	0.00144	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000149	0.00142	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000145	0.00137	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000139	0.00132	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000128	0.00121	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000124	0.00118	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000123	0.00117	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000121	0.00115	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000114	0.00108	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000112	0.00106	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	0.000108	0.00102	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—peripheral nervous system neoplasm	0.000105	0.001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	0.000103	0.000981	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	9.95e-05	0.000944	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.58e-05	0.000909	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.02e-05	0.000856	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.81e-05	0.000836	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.77e-05	0.000832	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.69e-05	0.000825	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.3e-05	0.000788	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.07e-05	0.000766	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8e-05	0.000759	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.97e-05	0.000756	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.33e-05	0.000696	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—peripheral nervous system neoplasm	7.31e-05	0.000694	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.29e-05	0.000691	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.79e-05	0.000644	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.71e-05	0.000636	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	6.53e-05	0.00062	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.25e-05	0.000593	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—peripheral nervous system neoplasm	5.69e-05	0.00054	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.57e-05	0.000529	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.52e-05	0.000524	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.33e-05	0.000506	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.27e-05	0.0005	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.19e-05	0.000492	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.13e-05	0.000487	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.91e-05	0.000465	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.71e-05	0.000447	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.33e-05	0.000411	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.24e-05	0.000402	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.16e-05	0.000394	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.14e-05	0.000109	CbGpPWpGaD
